CA
NZ
UK
AU
IND
US
IES Holdings, Inc. filed a Form 8-K on August 11, 2026, disclosing that it entered into a Transaction Agreement on August 7, 2026, to acquire DBM Global, Inc. from Innovate Corp. and DBM Global Intermediate Holdco Inc. for a base purchase price of $650,000,000, …
Beyond Meat, Inc. filed a Form 8-K on August 11, 2026, disclosing that its board of directors selected a 1-for-30 reverse stock split ratio, with the split and a related authorized share reduction expected to take effect on August 13, 2026.
A Statement of Changes in Beneficial Ownership was filed on August 11, 2026, reporting that Todd P. Kelsey, a director of Littelfuse Inc /DE (NASDAQ:LFUS), received a grant of 294 restricted stock units on August 6, 2026, at no cost to the recipient.
Autolus Therapeutics plc filed a Form 8-K with the U.S. Securities and Exchange Commission on August 11, 2026, announcing its financial results for the quarter ended June 30, 2026, and furnishing an updated corporate presentation used in a same-day conference call.
Unusual Machines, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing that it made an updated investor presentation available on its website on August 10, 2026, under Regulation FD.
Joby Aviation, Inc. filed a current report on Form 8-K on August 11, 2026, disclosing that on August 8, 2026, it entered into a Stock Purchase Agreement to acquire Strix Holdings, Inc. and its subsidiary Resonant Sciences, LLC for a base purchase price of …
Hanmi Financial Corporation filed a Form 8-K with the SEC on August 11, 2026, disclosing under Regulation FD that it had made available an investor slide presentation covering the company's operating and growth strategies and financial performance.
Butterfly Network, Inc. filed a current report on August 11, 2026, disclosing that board director Dr. Erica Schwartz resigned effective August 5, 2026, following her Senate confirmation as Director of the Centers for Disease Control and Prevention.
ManpowerGroup Inc. filed a Form 8-K on August 11, 2026, disclosing the appointment of John B. Gibson, Jr. to its Board of Directors, with service set to begin on September 1, 2026.
Veradermics, Incorporated filed a Current Report on Form 8-K with the SEC on August 11, 2026, announcing the issuance of a press release covering its financial results for the quarter ended June 30, 2026.
Please wait processing your request...